Tempus AI

Tempus AI, Inc. is a health technology company based in Chicago, Illinois, founded in 2015 by Eric Lefkofsky. The company focuses on precision medicine, utilizing data and artificial intelligence to enhance diagnostics in oncology, cardiology, radiology, and depression. Tempus went public on the Nasdaq in June 2024 and has a market cap of approximately $14 billion. The Tempus Platform is a comprehensive system that integrates clinical data with laboratory diagnostics and analytics. It features intelligent diagnostics that leverage AI for more accurate and personalized laboratory tests. Tempus offers three main product lines: genomics, data solutions for drug discovery, and AI applications for clinical decision support. The company serves a diverse range of clients, including physicians, researchers, pharmaceutical developers, insurers, and patients, particularly those with cancer and other health conditions. Tempus aims to improve patient care by providing tools that evolve with the accumulation of data.